Intellia Therapeutics Inc buy BMO Capital Markets
Start price
10.11.23
/
50%
€22.58
Target price
10.11.24
€58.01
Performance (%)
-30.16%
End price
11.11.24
€15.77
Summary
This prediction ended on 11.11.24 with a price of €15.77. Massive losses of -30.16% were the result for the BUY prediction by BMO_Capital_Markets. BMO_Capital_Markets has a follow-up prediction for Intellia Therapeutics Inc where he still thinks Intellia Therapeutics Inc is a Buy. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | -6.653% | -6.653% | -40.136% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by BMO_Capital_Markets for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at BMO Capital Markets from $64.00 to $62.00. They now have an "outperform" rating on the stock.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten
Current prediction by BMO_Capital_Markets for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€10.22
10.01.25
10.01.25
€48.67
10.01.26
10.01.26
-26.11%
15:06
15:06
Stopped prediction by BMO_Capital_Markets for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€22.72
10.05.24
10.05.24
€64.98
10.05.25
10.05.25
-67.39%
11.05.25
11.05.25
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€36.37
13.03.23
13.03.23
-
13.03.24
13.03.24
-27.88%
14.03.24
14.03.24